Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinyi Zhao

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Cancer Medicine|April 14, 2026
Risk Factors and Comparative Safety of Anti-PD-1 Combination Therapies in Advanced Melanoma: A Nationwide Real-World Cohort Study From ChinaYuan Qiao, Xiao Fu, Sundus Shukar, et al.
European Journal of Medicinal Chemistry|June 18, 2025
Design, synthesis, and evaluation of Menin-targeting compounds for the treatment of acute Myelocytic leukemia (AML)Jun Mo, Yuxian Wang, Youlu Pan, et al.
Cancer Immunology, Immunotherapy : CII|June 23, 2026
Efficacy and safety of anti-PD-1-based therapies in advanced melanoma across acral and mucosal subtypes: a nationwide retrospective cohort studyYuan Qiao, Xiao Fu, Iltaf Hussain, et al.
Signal Transduction and Targeted Therapy|March 5, 2024
Structure-based design of pan-coronavirus inhibitors targeting host cathepsin L and calpain-1Xiong Xie, Qiaoshuai Lan, Jinyi Zhao, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Cancer Medicine|April 14, 2026
Risk Factors and Comparative Safety of Anti-PD-1 Combination Therapies in Advanced Melanoma: A Nationwide Real-World Cohort Study From ChinaYuan Qiao, Xiao Fu, Sundus Shukar, et al.
European Journal of Medicinal Chemistry|June 18, 2025
Design, synthesis, and evaluation of Menin-targeting compounds for the treatment of acute Myelocytic leukemia (AML)Jun Mo, Yuxian Wang, Youlu Pan, et al.
Cancer Immunology, Immunotherapy : CII|June 23, 2026
Efficacy and safety of anti-PD-1-based therapies in advanced melanoma across acral and mucosal subtypes: a nationwide retrospective cohort studyYuan Qiao, Xiao Fu, Iltaf Hussain, et al.
Signal Transduction and Targeted Therapy|March 5, 2024
Structure-based design of pan-coronavirus inhibitors targeting host cathepsin L and calpain-1Xiong Xie, Qiaoshuai Lan, Jinyi Zhao, et al.
Pageof 7